Here, we survey 10 antidepressants that may change the mental health landscape in the coming years.
1. EsmethadoneThe (S)-enantiomer of methadone, esmethadone (dextromethadone; REL-1017) from Relmada Therapeutics (Nasdaq:RLMD) is headed to a Phase 3 study for major depressive disorder (MDD). The drug candidate was efficacious on days 4, 7 a…